glycopyrrolate · Merz Pharms · NDA 022571
Cuvposa
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220062, Bionpharma · 022571-001Approved 23 Dec 2025Detected 25 Oct 2026Historical import
- Generic approved · ANDA 219267, Ajenat Pharms · 022571-001Approved 27 Oct 2025Detected 25 Oct 2026Historical import
- Generic approved · ANDA 216910, Quagen · 022571-001Approved 18 May 2026Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022571 · 001 · RLD | solution, oral | 1MG/5ML | open |